UniProt ID | BYST_HUMAN | |
---|---|---|
UniProt AC | Q13895 | |
Protein Name | Bystin | |
Gene Name | BYSL | |
Organism | Homo sapiens (Human). | |
Sequence Length | 437 | |
Subcellular Localization | Cytoplasm . Nucleus, nucleolus . Associated with 40S ribosomal subunits. | |
Protein Description | Required for processing of 20S pre-rRNA precursor and biogenesis of 40S ribosomal subunits. May be required for trophinin-dependent regulation of cell adhesion during implantation of human embryos.. | |
Protein Sequence | MPKFKAARGVGGQEKHAPLADQILAGNAVRAGVREKRRGRGTGEAEEEYVGPRLSRRILQQARQQQEELEAEHGTGDKPAAPRERTTRLGPRMPQDGSDDEDEEWPTLEKAATMTAAGHHAEVVVDPEDERAIEMFMNKNPPARRTLADIIMEKLTEKQTEVETVMSEVSGFPMPQLDPRVLEVYRGVREVLSKYRSGKLPKAFKIIPALSNWEQILYVTEPEAWTAAAMYQATRIFASNLKERMAQRFYNLVLLPRVRDDVAEYKRLNFHLYMALKKALFKPGAWFKGILIPLCESGTCTLREAIIVGSIITKCSIPVLHSSAAMLKIAEMEYSGANSIFLRLLLDKKYALPYRVLDALVFHFLGFRTEKRELPVLWHQCLLTLVQRYKADLATDQKEALLELLRLQPHPQLSPEIRRELQSAVPRDVEDVPITVE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Ubiquitination | -----MPKFKAARGV -----CCCCCCCCCC | 59.19 | 24816145 | |
5 | Methylation | ---MPKFKAARGVGG ---CCCCCCCCCCCC | 47.46 | - | |
8 | Methylation | MPKFKAARGVGGQEK CCCCCCCCCCCCCCC | 45.23 | - | |
15 | Acetylation | RGVGGQEKHAPLADQ CCCCCCCCCCCHHHH | 36.86 | 21466224 | |
15 | Ubiquitination | RGVGGQEKHAPLADQ CCCCCCCCCCCHHHH | 36.86 | 19608861 | |
30 | Methylation | ILAGNAVRAGVREKR HHHCHHHHHCHHCHH | 24.18 | - | |
38 | Methylation | AGVREKRRGRGTGEA HCHHCHHCCCCCCCC | 50.67 | - | |
40 | Methylation | VREKRRGRGTGEAEE HHCHHCCCCCCCCHH | 37.37 | 24129315 | |
42 | Phosphorylation | EKRRGRGTGEAEEEY CHHCCCCCCCCHHHH | 30.41 | 21945579 | |
49 | Phosphorylation | TGEAEEEYVGPRLSR CCCCHHHHHHHHHHH | 17.62 | 21945579 | |
55 | Phosphorylation | EYVGPRLSRRILQQA HHHHHHHHHHHHHHH | 22.31 | 25159151 | |
75 | Phosphorylation | ELEAEHGTGDKPAAP HHHHHHCCCCCCCCC | 44.08 | 22210691 | |
78 | Acetylation | AEHGTGDKPAAPRER HHHCCCCCCCCCCCC | 37.59 | 25953088 | |
78 | Ubiquitination | AEHGTGDKPAAPRER HHHCCCCCCCCCCCC | 37.59 | 29967540 | |
86 | Phosphorylation | PAAPRERTTRLGPRM CCCCCCCCCCCCCCC | 16.12 | 26074081 | |
87 | Phosphorylation | AAPRERTTRLGPRMP CCCCCCCCCCCCCCC | 30.07 | 29496963 | |
98 | Phosphorylation | PRMPQDGSDDEDEEW CCCCCCCCCCCCCCC | 50.61 | 22167270 | |
107 | Phosphorylation | DEDEEWPTLEKAATM CCCCCCCHHHHHHHH | 48.93 | 22167270 | |
113 | Phosphorylation | PTLEKAATMTAAGHH CHHHHHHHHHHCCCC | 21.66 | 26074081 | |
139 | Ubiquitination | AIEMFMNKNPPARRT HHHHHHCCCCCHHHH | 60.07 | 24816145 | |
152 | Sulfoxidation | RTLADIIMEKLTEKQ HHHHHHHHHHHHHCC | 3.67 | 21406390 | |
154 | Ubiquitination | LADIIMEKLTEKQTE HHHHHHHHHHHCCHH | 43.24 | 21906983 | |
154 | 2-Hydroxyisobutyrylation | LADIIMEKLTEKQTE HHHHHHHHHHHCCHH | 43.24 | - | |
154 | Acetylation | LADIIMEKLTEKQTE HHHHHHHHHHHCCHH | 43.24 | 27452117 | |
156 | Phosphorylation | DIIMEKLTEKQTEVE HHHHHHHHHCCHHHH | 52.80 | 28188228 | |
158 | Ubiquitination | IMEKLTEKQTEVETV HHHHHHHCCHHHHHH | 58.23 | 22817900 | |
160 | Phosphorylation | EKLTEKQTEVETVMS HHHHHCCHHHHHHHH | 53.73 | 21712546 | |
164 | Phosphorylation | EKQTEVETVMSEVSG HCCHHHHHHHHHHCC | 27.04 | 21712546 | |
167 | Phosphorylation | TEVETVMSEVSGFPM HHHHHHHHHHCCCCC | 30.43 | 21712546 | |
170 | Phosphorylation | ETVMSEVSGFPMPQL HHHHHHHCCCCCCCC | 30.57 | 21712546 | |
185 | Phosphorylation | DPRVLEVYRGVREVL CHHHHHHHHHHHHHH | 7.71 | 28634298 | |
186 | Methylation | PRVLEVYRGVREVLS HHHHHHHHHHHHHHH | 42.16 | - | |
194 | Ubiquitination | GVREVLSKYRSGKLP HHHHHHHHHHCCCCC | 40.29 | 29967540 | |
195 | Phosphorylation | VREVLSKYRSGKLPK HHHHHHHHHCCCCCH | 13.46 | 23532336 | |
197 | Phosphorylation | EVLSKYRSGKLPKAF HHHHHHHCCCCCHHH | 36.87 | 23532336 | |
220 | Phosphorylation | WEQILYVTEPEAWTA CEEEEEECCHHHHHH | 32.06 | 24719451 | |
226 | Phosphorylation | VTEPEAWTAAAMYQA ECCHHHHHHHHHHHH | 17.29 | 24719451 | |
231 | Phosphorylation | AWTAAAMYQATRIFA HHHHHHHHHHHHHHH | 7.11 | 24719451 | |
242 | Ubiquitination | RIFASNLKERMAQRF HHHHHCHHHHHHHHH | 47.74 | 21963094 | |
250 | Phosphorylation | ERMAQRFYNLVLLPR HHHHHHHHHHCCHHH | 15.13 | 28152594 | |
265 | Phosphorylation | VRDDVAEYKRLNFHL CCCCHHHHHHHCHHH | 7.53 | 24248375 | |
266 | Ubiquitination | RDDVAEYKRLNFHLY CCCHHHHHHHCHHHH | 41.75 | 24816145 | |
277 | Acetylation | FHLYMALKKALFKPG HHHHHHHHHHHCCCC | 26.85 | 25953088 | |
282 | Ubiquitination | ALKKALFKPGAWFKG HHHHHHCCCCCCCCC | 43.31 | 29967540 | |
282 | Acetylation | ALKKALFKPGAWFKG HHHHHHCCCCCCCCC | 43.31 | 26051181 | |
322 | Phosphorylation | CSIPVLHSSAAMLKI CCCCCCCCCHHHHHH | 19.94 | 24260401 | |
332 | Sulfoxidation | AMLKIAEMEYSGANS HHHHHHHHHCCCCCH | 4.30 | 28183972 | |
349 | Ubiquitination | LRLLLDKKYALPYRV HHHHHCCCCCCCHHH | 35.11 | 24816145 | |
349 | 2-Hydroxyisobutyrylation | LRLLLDKKYALPYRV HHHHHCCCCCCCHHH | 35.11 | - | |
389 | Phosphorylation | LLTLVQRYKADLATD HHHHHHHHHHCCCCC | 8.08 | 28152594 | |
390 | Ubiquitination | LTLVQRYKADLATDQ HHHHHHHHHCCCCCH | 37.30 | 24816145 | |
395 | Phosphorylation | RYKADLATDQKEALL HHHHCCCCCHHHHHH | 46.38 | 28152594 | |
398 | Sumoylation | ADLATDQKEALLELL HCCCCCHHHHHHHHH | 48.00 | - | |
398 | Ubiquitination | ADLATDQKEALLELL HCCCCCHHHHHHHHH | 48.00 | 21906983 | |
398 | Sumoylation | ADLATDQKEALLELL HCCCCCHHHHHHHHH | 48.00 | - | |
414 | Phosphorylation | LQPHPQLSPEIRREL HCCCCCCCHHHHHHH | 18.42 | 20873877 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of BYST_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BYST_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BYST_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-15, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98 AND SER-167, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98, AND MASSSPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98, AND MASSSPECTROMETRY. |